ロード中...

In Vitro Activity of Cefepime/AAI101 and Comparators against Cefepime Non-susceptible Enterobacteriaceae

We evaluated the in vitro potency of cefepime combined with AAI101, a novel extended-spectrum β-lactamase inhibitor, against a population of clinical Escherichia coli and Klebsiella pneumoniae collected from USA hospitals. Of the 223 cefepime non-susceptible isolates, 95% were ceftazidime non-suscep...

詳細記述

保存先:
書誌詳細
出版年:Pathogens
主要な著者: Crandon, Jared L., Nicolau, David P.
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4584277/
https://ncbi.nlm.nih.gov/pubmed/26295262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pathogens4030620
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!